logo

[breadcrumb_custom]

The IBIO Stock Puzzle: Unraveling iBio Inc’s Fluctuating Performance

iBio Inc’s market performance has been unstable in recent times. The company’s stock hit a 1-year high of $49.80 on 03/28/23 and a low of $1.02 for the same time frame on 01/18/24.

52-week price history of IBIO Stock

A stock’s 52-week high and low prices can reveal much about its current status and future trajectory. iBio Inc’s current trading price is -94.52% away from its 52-week high, while its distance from the 52-week low is 167.38%. The stock’s price range during this period has spanned from $1.02 to $49.80. In the Healthcare sector, the iBio Inc’s shares surpassed a trading volume of approximately 113.65 million for the day, which was noticeably higher compared to the average daily volume of 9.0.11 million over the past three months.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free
Sponsored

Market Capitalization and Financial Performance: An In-Depth Look

iBio Inc (IBIO) has experienced a quarterly rise of 93.69% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 9.50M and boasts a workforce of 26 employees.

Making Sense of Trading Volume and Moving Average Data

Based on Barchart.com data, the company’s moving average over the 100-day period was 2.0794, with a change in price of -2.7141. Similarly, iBio Inc recorded 1,263,223 in trading volume during the last 100 days, posting a change of -50.98%.

Examining IBIO’s Debt-to-Equity Ratio: What You Need to Know

The debt-to-equity (D/E) ratio is a crucial measure that sheds light on a company’s financial health and market standing. It is determined by dividing a company’s overall liabilities by its shareholders’ equity, showing the extent of a company’s debt usage in financing its assets compared to the shareholders’ equity. At the time of writing, the total D/E ratio for IBIO stands at 1.79. Similarly, the long-term debt-to-equity ratio is also 0.34.

IBIO Stock Stochastic Average

Today, iBio Inc’s raw stochastic average for the past 50 days stands at 69.71%, indicating a rise from the raw stochastic average of the last 20 days, which was 69.33%. Moreover, the company’s Stochastic %K and %D values over the past 20 days were 42.44% and 27.48% respectively.

IBIO Stock Price Performance Analysis

A mixed performance in the stock price over the year has left investors with either an optimistic or pessimistic outlook, depending on their point of view. Until today this year the stock’s price performance recorded an increase of 99.34%. However, over the last six months, the performance has been stronger by -54.13%. The price of IBIO increased 133.42% over the last 30 days. And in the last five days, it has surged by 155.23%.

On Key

Related Posts